Isabelle Rapin

Professor
Albert Einstein College of Medicine

Isabelle Rapin is a retired child neurologist. She was a faculty member at the Albert Einstein College of Medicine from 1958-2012, where she worked as a clinician, a teacher and a researcher. She became interested in communication disorders in children, including, in retrospect, some with autism spectrum disorders (ASDs), as a neurology resident and child neurology fellow at the Neurological Institute of New York/Columbia-Presbyterian Hospital (1954-1958). As co-investigator of a number of genetic diseases of the nervous system in children, Rapin has done National Institutes of Health-supported clinical research in childhood deafness, developmental disorders and autism spectrum disorders. She is the author or co-author of some 300 papers and chapters, author of one book and editor or co-editor of ten books, many concerned with communication in ASDs. She has participated in training more than 75 child neurology fellows and many pediatric and neurology residents, was active in national and international neurology and child neurology associations, and has lectured widely in the U.S. and abroad, frequently on topics relevant to ASDs.

 

From this contributor

Explore more from The Transmitter

Research image of cell-surface protein LPHN2.

‘Push-pull’ recipe for neural wiring used in multiple brain regions

A versatile pair of proteins steers neurons toward their targets and helps establish the brain’s sensory maps, new studies suggest.

By Holly Barker
5 June 2026 | 5 min read
Research image showing dopamine level spikes.

Reward-learning algorithm hardwired into dopamine circuit

The finding bolsters the canonical model of reward prediction error, which has come under scrutiny in recent years.

By Natalia Mesa
5 June 2026 | 5 min read
Burke Neurological Institute.

Exclusive: Brain and spinal cord institute halts research, citing funding problems

The Burke Neurological Institute, which calls itself “the only research institute in the U.S. dedicated to finding treatments to repair the brain and spinal cord,” ceased research operations on 22 May.

By Lauren Schenkman
4 June 2026 | 5 min read